Literature DB >> 28645707

Syndemic Factors Mediate the Relationship between Sexual Stigma and Depression among Sexual Minority Women and Gender Minorities.

Carmen H Logie1, Ashley Lacombe-Duncan2, Tonia Poteat3, Anne C Wagner4.   

Abstract

INTRODUCTION: Stigma and discrimination contribute to elevated depression risks among sexual minority women (SMW) and gender minority (GM) people who identify as lesbian, bisexual, or queer. Syndemics theory posits that adverse psychosocial outcomes cluster to negatively impact health and mental health outcomes among sexual minorities. We tested whether a syndemic condition composed of low social support, low self-rated health, low self-esteem, and economic insecurity mediated the relationship between sexual stigma and depressive symptoms among SMW/GM.
METHODS: We implemented a cross-sectional, Internet-based survey with SMW and GM in Toronto, Canada. We conducted structural equation modeling using maximum likelihood estimation to test a conceptual model of pathways between sexual stigma, syndemic factors, and depressive symptoms.
RESULTS: A total of 391 SMW/GM with a mean age of 30.9 (SD = 7.62) were included in the analysis. The model fit for a latent syndemics construct consisting of psychosocial variables (low social support, low self-rated health, low self-esteem, economic insecurity) was very good (χ2 = 6.022, df = 2, p = .049; comparative fit index = 0.973, Tucker-Lewis index = 0.918, root-mean square error of approximation = 0.072). In the simultaneous model, sexual stigma had a significant direct effect on depression. When the syndemic variable was added as a mediator, the direct path from sexual stigma to depression was no longer significant, suggesting mediation. The model fit the data well: χ2 = 33.50, df = 12, p = .001; comparative fit index = 0.951, Tucker-Lewis index = 0.915, root-mean square error of approximation = 0.068.
CONCLUSIONS: Our results highlight the salience of considering both sexual stigma and syndemic factors to explain mental health disparities experienced by SMW and GM. Addressing sexual stigma in the context of co-occurring psychosocial factors and economic insecurity will be key to achieving optimal health for SMW and GM.
Copyright © 2017 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28645707     DOI: 10.1016/j.whi.2017.05.003

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  5 in total

1.  A latent class analysis of tailored substance use treatment programs: Implications for treating syndemic conditions facing sexual and gender minority populations.

Authors:  Emily C Helminen; Cory J Cascalheira; Thomas J Shaw; Sarah Zollweg; Tonda L Hughes; Jillian R Scheer
Journal:  Drug Alcohol Depend       Date:  2022-06-30       Impact factor: 4.852

2.  Discrimination and mental health in the minority sexual population: Cross-sectional analysis of the first peruvian virtual survey.

Authors:  David R Soriano-Moreno; David Saldaña-Cabanillas; Luigy Vasquez-Yeng; Javier Antonio Valencia-Huamani; Jorge Luis Alave-Rosas; Anderson N Soriano
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

3.  Longitudinal associations between minority stress, internalizing symptoms, and substance use among sexual and gender minority individuals assigned female at birth.

Authors:  Christina Dyar; Elissa L Sarno; Michael E Newcomb; Sarah W Whitton
Journal:  J Consult Clin Psychol       Date:  2020-01-23

4.  A Nationwide Survey of COVID-19 Testing in LGBTQ+ Populations in the United States.

Authors:  Richard J Martino; Kristen D Krause; Marybec Griffin; Caleb LoSchiavo; Camilla Comer-Carruthers; Anita G Karr; Allie F Bullock; Perry N Halkitis
Journal:  Public Health Rep       Date:  2021-05-25       Impact factor: 3.117

5.  Conceptualizing LGBT Stigma and Associated HIV Vulnerabilities Among LGBT Persons in Lesotho.

Authors:  Carmen H Logie; Amaya Perez-Brumer; Tampose Mothopeng; Maya Latif; Amelia Ranotsi; Stefan D Baral
Journal:  AIDS Behav       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.